Expert Answer
Quick Answer
Weight regain is common. Attia says GLP-1s are "best used indefinitely," and Dr. Ralph DeFronzo notes high relapse rates after stopping. The bigger risk: you can regain fat without the muscle you lost — worse body composition than you started. Lifestyle changes built while on the drug improve your odds of holding the loss.
Moderate Consensus
on GLP-1 Agonists overall
Advises GLP-1s are best used indefinitely because regain is common; people who build better habits while on the drug have a better chance of maintaining loss after stopping.
Warns against on/off "yo-yo" cycling; favors slow, steady dosing and (via Bikman) a defined off-ramp paired with permanent habit change.
Sees common regain as evidence the drugs mask root causes rather than fix the underlying food and metabolic environment.
The uncomfortable consensus: for most people, stopping a GLP-1 means the weight comes back. Attia is direct that these drugs are "best used indefinitely," because appetite and food-noise return to baseline once the drug clears. Dr. Ralph DeFronzo (via Attia) confirms high relapse rates on discontinuation — and notes many people stop within a year anyway, driven by cost (around $1,000/month) and side effects.
The regain has a sharper edge than simple weight return. If you lost muscle on the way down (see the muscle-loss question) and then regain fat without regaining that muscle, you can end up with worse body composition than you started — a point Dr. Ben Bikman (via Diary of a CEO) stresses. This is the strongest argument for defending muscle aggressively while you are on the drug.
Is there an off-ramp? Some clinicians think so. Bikman frames microdosing plus behavioral coaching as a roughly 90-day tool to rewire cravings so you can taper off, and Patrick favors slow, steady dosing over aggressive on/off "yo-yo" cycling. Attia's pragmatic version: use the time on the drug to build the habits — protein, training, sleep, food quality — that give you a fighting chance of holding the loss if you come off. Hyman reads the high regain rate as the core problem: a drug that has to be taken forever, he argues, is masking the root cause rather than fixing it.
Usually, yes. Attia calls indefinite use the default because appetite returns; DeFronzo notes high relapse rates. Habits built while on the drug improve your odds of keeping it off.
Some clinicians (Bikman via Patrick) frame microdosing plus coaching as a ~90-day off-ramp to rewire cravings. It is plausible but under-studied; do it with a prescriber.
Regaining fat without the muscle you lost, leaving worse body composition than baseline. That is why defending muscle with protein and training while on the drug matters so much.
This page covers what researchers agree on. Pro gives you the specific dosages, timing schedules, and interaction warnings they each recommend — with video citations you can verify.
Cancel anytime
Full GLP-1 Agonists Consensus Report
See what all the experts agree and disagree on